Understanding how to maintain weight loss after tirzepatide and the role of a GLP-1 maintenance dose in long-term weight management is critical for sustaining results
A consolidated list of all the FDA approved medications during the month of February 2026
Hematol/Oncol Clin North Am
Future Med Chem 16(24):26472662 Abdel-Fattah MM, Hassanein EHM, Sayed AM, Alsufyani SE, El-Sheikh AAK, Arab HH et al (2023) Targeting SIRT1/FoxO3a/Nrf2 and PI3K/AKT pathways with rebamipide attenuates acetic acid-induced colitis in rats
After reviewing data submitted to the FDAs Adverse Event Reporting System between 2018 and 2024, McCall and his coauthors found that compounded GLP-1 medicines were correlated with a greater likelihood of abdominal pain, nausea, diarrhea, gallbladder inflammation, and suicidality compared to standard formulations, as well as more frequent hospitalization for those adverse effects
PSYCHIATRIC ADVERSE EFFECTS Evidence based on recent studies While GLP-1 RAs have demonstrated potent glucose-lowering effects, their impact on diabetic retinopathy remains incompletely elucidated
